Skip to main content
Log in

The correlation between cutaneous IgM deposition and renal involvement in adult patients with Henoch-Schönlein purpura

  • Clinical Report
  • Published:
European Journal of Dermatology Aims and scope

Abstract

Background

Henoch-Schönlein purpura (HSP) is a systemic and immune complex-related leukocytoclastic vasculitis. A positive correlation has been found between IgM deposition along with IgA in skin lesions diagnosed by direct immunofluorescence (DIF) and renal involvement with HSP.

Objectives

We sought to investigate the relationship between the systemic associations of the disease and the severity of the skin lesions, as well as the immune deposition findings of the lesional skin provided by DIF in patients with HSP.

Materials & Methods

Between 2001 and 2012, 47 patients with HSP were investigated at our dermatology clinic. Epidemiologic data, laboratory findings, localizations of the palpable purpura, existence of bulla or necrosis in the skin lesions, accompanying systemic involvement, and DIF findings of skin biopsy specimens were recorded.

Results

Of the 47 patients 22 were men and 25 were women (age range 16–88 years, mean 42.2). Among all cases with skin involvement, we found 22 (46.8%) articular involvement, 20 (42.6%) renal involvement and 12 (25.5%) gastrointestinal tract involvement. The frequency of bulla and/or necrosis in the skin lesions was significantly high in patients with gastrointestinal and renal involvement (p<0.05). The risk of renal involvement was significantly high in patients whose DIF examination revealed IgM deposition (p<0.05). No association was found between systemic involvement and IgG, complement 3 (C3) and fibrinogen deposition.

Conclusion

Patients with HSP, having bullous and/or necrotic lesions and whose skin DIF investigations reveal IgM deposition along with IgA, should be surveyed for the risk of renal involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aoki V, Sousa JX Jr., Fukumori LM, Périgo AM, Freitas EL, Oliveira ZN. Direct and indirect immunofluorescence. An Bras Dermatol 2010; 85: 490–500.

    Article  PubMed  Google Scholar 

  2. Jennette JC, Falk RJ. The role of pathology in the diagnosis of systemic vasculitis. Clin Exp Rheumatol 2007; 25: 52–56.

    Google Scholar 

  3. Saulsbury FT. Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999; 78: 395–409.

    Article  CAS  Google Scholar 

  4. Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005; 35: 143–153.

    Article  PubMed  Google Scholar 

  5. Takeuchi S, Soma Y, Kawakami T. IgM in lesional skin of adults with Henoch-Schönlein purpura is an indication of renal involvement. J Am Acad Dermatol 2010; 63: 1026–1029.

    Article  CAS  PubMed  Google Scholar 

  6. Poterucha TJ, Wetter DA, Gibson LE, Camilleri MJ, Lohse CM. Correlates of systemic disease in adult Henoch-Schönlein purpura: a retrospective study of direct immunofluorescence and skin lesion distribution in 87 patients at Mayo Clinic. J Am Acad Dermatol 2012; 67: 612–616.

    Article  PubMed  Google Scholar 

  7. Jauhola O, Ronkainen J, Koskimies O, et al. Clinical course of extrarenal symptoms in Henoch-Schönlein purpura: a 6-month prospective study. Arch Dis Child 2010; 95: 871–876.

    Article  PubMed  Google Scholar 

  8. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008; 9: 71–92.

    Article  PubMed  Google Scholar 

  9. Saulsbury FT. Clinical update: Henoch-Schönlein purpura. Lancet 2007; 369: 976–978.

    Article  PubMed  Google Scholar 

  10. Chang WL, Yang YH, Lin YT, Chiang BL. Gastrointestinal manifestations in Henoch-Schönlein purpura: a review of 261 patients. Acta Paediatr 2004; 93: 1427–1431.

    Article  PubMed  Google Scholar 

  11. Stewart M, Savage JM, Bell B, McCord B. Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population. Eur J Pediatr 1988; 147: 113–115.

    Article  CAS  PubMed  Google Scholar 

  12. Koskimies O, Mir S, Rapola J, Vilska J. Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child 1981; 56: 482–484.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schönlein purpura. Eur J Pediatr 2002; 161: 196–201.

    Article  CAS  PubMed  Google Scholar 

  14. Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL. Renal manifestations in Henoch-Schönlein purpura: a 10-year clinical study. Pediatr Nephrol 2005; 20: 1269–1272.

    Article  PubMed  Google Scholar 

  15. Kawasaki Y, Ono A, Ohara S, et al. Henoch-schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment. Fukushima J Med Sci 2013; 59: 15–26.

    Article  PubMed  Google Scholar 

  16. Tizard EJ, Hamilton-Ayres MJ. Henoch Schonlein purpura. Arch Dis Child Educ Pract Ed 2008; 93: 1–8.

    Article  CAS  PubMed  Google Scholar 

  17. White RH. Henoch-Schönlein nephritis. A disease with significant late sequelae. Nephron 1994; 68: 1–9.

    CAS  Google Scholar 

  18. Lau KK, Suzuki H, Novak J, Wyatt RJ. Pathogenesis of Henoch-Schönlein purpura nephritis. Pediatr Nephrol 2010; 25: 19–26.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Garland JS, Chusid MJ. Henoch-Schoenlein purpura: association with unusual vesicular lesions. Wis Med J 1985; 84: 21–23.

    CAS  PubMed  Google Scholar 

  20. Wananukul S, Pongprasit P, Korkij W. Henoch-Schonlein purpura presenting as hemorrhagic vesicles and bullae: case report and literature review. Pediatr Dermatol 1995; 12: 314–317.

    Article  CAS  PubMed  Google Scholar 

  21. Saulsbury FT. Hemorrhagic bullous lesions in Henoch-Schönlein purpura. Pediatr Dermatol 1998; 15: 357–359.

    Article  CAS  PubMed  Google Scholar 

  22. Ishii Y, Takizawa T, Arakawa H, et al. Hemorrhagic bullous lesions in Henoch-Schönlein purpura. Pediatr Int 2005; 47: 694–697.

    Article  PubMed  Google Scholar 

  23. Aydinoz S, Karademir F, Suleymanoglu S, Ozkaya H, Ersen A, Gocmen I. Medical images. An unusual manifestation of Henoch-Schonlein purpura: haemorrhagic bullous lesions. N Z Med J 2007; 120: 2870.

    Google Scholar 

  24. Tirado-Sánchez A, Bonifaz A, Ponce-Olivera RM. IgM in lesional skin is indicative of renal involvement in adults with Henoch-Schönlein purpura but not children. J Am Acad Dermatol 2011; 64: 1183–1184.

    Article  PubMed  Google Scholar 

  25. Chhabra S, Minz RW, Saikia B. Immunofluorescence in dermatology. Indian J Dermatol Venereol Leprol 2012; 78: 677–691.

    Article  PubMed  Google Scholar 

  26. Liu Z, Li L. Significance of IgM deposition in IgA nephropathy: an appraisal based on renal re-biopsy. Zhonghua Yi Xue Za Zhi 1990; 70: 324–326, 24.

    CAS  PubMed  Google Scholar 

  27. Ibels LS, Györy AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994; 73: 79–102.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Asli Akin Belli.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Belli, A.A., Dervis, E. The correlation between cutaneous IgM deposition and renal involvement in adult patients with Henoch-Schönlein purpura. Eur J Dermatol 24, 81–84 (2014). https://doi.org/10.1684/ejd.2013.2243

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2013.2243

Key words

Navigation